Suppression of tumor growth via IGFBP3 depletion as a potential treatment in glioma

Abstract

Our findings suggest IGFBP3 predicts poor outcome of glioma patients and is a potential therapeutic target for which depletion of its expression suppresses tumor growth through inducing apoptosis and accumulation of DNA damage in glioma cells.